Ventricular stiffening and chamber contracture in heart failure with higher ejection fraction
Abstract
Ancillary analyses from clinical trials have suggested reduced efficacy for neurohormonal antagonists among patients with heart failure and preserved ejection fraction (HFpEF) and higher ranges of ejection fraction (EF).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 12, 2023
- Source ID
- 10.1002/ejhf.2843
Entities
People
- Alessio Alogna
- Barry A Borlaug
- Daniel Burkhoff
- Dejana Popovic
- Hidemi Sorimachi
- Kazunori Omote
- Margaret M. Redfield
- Massar Omar
- Yogesh N.v. Reddy
Organizations
- Cardiovascular Research Foundation
- Charité
- Congressionally Directed Medical Research Programs
- Mayo Clinic
- Steno Diabetes Center